voltaren rapid 25
haleon new zealand ulc - diclofenac potassium 25mg; ; ; ; - tablet - 25 mg - active: diclofenac potassium 25mg excipient: calcium phosphate colloidal silicon dioxide dispersed red (ferric oxide 3% + titanium dioxide 97%) macrogol 8000 magnesium stearate maize starch microcrystalline cellulose opacode brown s-1-9210hv povidone purified talc sodium starch glycolate sucrose - short-term treatment in the following acute conditions: - post-traumatic pain, inflammation and swelling, e.g. due to sprains; - post-operative pain, inflammation and swelling, e.g. following dental or orthopaedic surgery; - painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; - migraine attacks; - painful syndromes of the vertebral column; - non-articular rheumatism; - as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.
voltaren 50 suppository 50 mg
novartis (singapore) pte ltd - diclofenac sodium - suppository - 50 mg - diclofenac sodium 50 mg
voltaren 50 tablet 50 mg
novartis (singapore) pte ltd - diclofenac sodium - enteric coated tablet - 50 mg - diclofenac sodium 50 mg
voltaren rapid tablets sugar-coated
novartis saglik - diclofenac (diclofenac potassium) - tablets sugar-coated - 50mg
voltaren rapid tablets sugar-coated
novartis saglik - diclofenac (diclofenac potassium) - tablets sugar-coated - 25mg
voltaren sr 100 tablet
novartis corporation (malaysia) sdn. bhd. - diclofenac sodium -
voltaren suppository 12.5mg
novartis corporation (malaysia) sdn. bhd. - diclofenac sodium -
voltaren suppository 25mg
novartis corporation (malaysia) sdn. bhd. - diclofenac sodium -
voltaren suppository 50mg
novartis corporation (malaysia) sdn. bhd. - diclofenac sodium -
voltaren sr 75mg film coated tablet
novartis corporation (malaysia) sdn. bhd. - diclofenac sodium -